1. Subject is at least 18 years old. 
2. Subject requires single- or multi-vessel percutaneous coronary intervention (PCI) of de novo or restenotic target lesion (including in-stent restenotic lesions). 
3. Subject's lesion(s) is (are) amenable to stent treatment with currently available FDA-approved bare metal or drug eluting stents. 
4. Subject is an acceptable candidate for elective, urgent or emergency coronary artery bypass graft (CABG). 
5. Subject has clinical evidence of ischemic heart disease in terms of a positive functional study, or documented symptoms. 
6. Documented stable angina pectoris [Canadian Cardiovascular Society Classification (CCS) 1, 2, 3, or 4], unstable angina pectoris with documented ischemia (Braunwald Class IB-C, IIB-C, or IIIB-C), non-ST segment elevation myocardial infarction, or documented silent ischemia. 
7. Subject is willing and able to undergo percutaneous intervention at SOS hospital, if randomized to SOS study arm. 
8. Subject and the treating physician agree that the subject will comply with all follow-up evaluations. 
9. Subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical site. 
10. The target lesion(s) is (are) de novo or restenotic (including in-stent restenotic) native coronary artery lesion(s) with greater than 50 and less than 100% stenosis (visual estimate), or the target lesion is an acute (less than 1 month) total occlusion as evidenced by clinical symptoms. 
11. Target lesions(s) is (are) located in an infarct (if not treated with primary PCI) or non-infarct-related artery with a 70% or greater stenosis (by visual estimate) more than 72 hours following the ST segment elevation myocardial infarction (STEMI). 
Lesions treated with PCI more than 72 hours following STEMI would be subject to the same protocol inclusion/exclusion criteria listed above and below with the exception that a target lesion of 70% or greater stenosis may be treated with or without symptoms or abnormal stress test). 

NCT01116882_inc_T1
Value
at least 18 years
NCT01116882_inc_T2
Person
old
NCT01116882_inc_T3
Procedure
percutaneous coronary intervention (PCI)
NCT01116882_inc_T4
Qualifier
single- vessel
NCT01116882_inc_T5
Qualifier
multi-vessel
NCT01116882_inc_T6
Scope
single- or multi-vessel
NCT01116882_inc_T8
Condition
target lesion
NCT01116882_inc_T9
Condition
in-stent restenotic lesions
NCT01116882_inc_T10
Qualifier
de novo
NCT01116882_inc_T11
Qualifier
restenotic
NCT01116882_inc_T12
Qualifier
in-stent
NCT01116882_inc_T13
Qualifier
restenotic
NCT01116882_inc_T14
Scope
de novo or restenotic target lesion
NCT01116882_inc_T15
Scope
de novo or restenotic target lesion (including in-stent restenotic lesions)
NCT01116882_inc_T16
Device
drug eluting stents
NCT01116882_inc_T17
Condition
amenable to stent treatment
NCT01116882_inc_T18
Device
bare metal stents
NCT01116882_inc_T19
Scope
bare metal or drug eluting stents
NCT01116882_inc_T20
Condition
coronary artery bypass graft (CABG)
NCT01116882_inc_T21
Qualifier
emergency
NCT01116882_inc_T22
Qualifier
urgent
NCT01116882_inc_T23
Qualifier
elective
NCT01116882_inc_T24
Scope
elective, urgent or emergency
NCT01116882_inc_T25
Condition
ischemic heart disease
NCT01116882_inc_T26
Observation
clinical evidence
NCT01116882_inc_T27
Procedure
functional study
NCT01116882_inc_T28
Value
positive
NCT01116882_inc_T29
Condition
stable angina pectoris
NCT01116882_inc_T30
Measurement
Canadian Cardiovascular Society Classification (CCS)
NCT01116882_inc_T31
Value
1, 2, 3, or 4
NCT01116882_inc_T32
Qualifier
stable
NCT01116882_inc_T33
Qualifier
unstable
NCT01116882_inc_T34
Condition
unstable angina pectoris
NCT01116882_inc_T35
Condition
ischemia
NCT01116882_inc_T36
Observation
documented
NCT01116882_inc_T37
Measurement
Braunwald Class
NCT01116882_inc_T38
Value
IB-C, IIB-C, or IIIB-C
NCT01116882_inc_T39
Condition
non-ST segment elevation myocardial infarction
NCT01116882_inc_T40
Condition
silent ischemia
NCT01116882_inc_T41
Qualifier
silent
NCT01116882_inc_T42
Observation
documented
NCT01116882_inc_T43
Procedure
percutaneous intervention
NCT01116882_inc_T44
Observation
willing
NCT01116882_inc_T45
Observation
able
NCT01116882_inc_T46
Visit
SOS hospital
NCT01116882_inc_T50
Qualifier
de novo
NCT01116882_inc_T51
Condition
target lesion
NCT01116882_inc_T7
Scope
de novo or restenotic
NCT01116882_inc_T52
Qualifier
restenotic
NCT01116882_inc_T53
Qualifier
in-stent restenotic
NCT01116882_inc_T54
Scope
de novo or restenotic
NCT01116882_inc_T55
Scope
de novo or restenotic (including in-stent restenotic)
NCT01116882_inc_T56
Condition
coronary artery lesion
NCT01116882_inc_T57
Value
greater than 50 and less than 100%
NCT01116882_inc_T58
Measurement
stenosis
NCT01116882_inc_T59
Condition
stenosis
NCT01116882_inc_T60
Condition
target lesion
NCT01116882_inc_T61
Temporal
acute
NCT01116882_inc_T62
Temporal
less than 1 month
NCT01116882_inc_T63
Condition
total occlusion
NCT01116882_inc_T64
Observation
clinical symptoms
NCT01116882_inc_T65
Condition
Target lesions
NCT01116882_inc_T66
Condition
infarct
NCT01116882_inc_T67
Qualifier
in an infarct -related artery
NCT01116882_inc_T68
Procedure
primary PCI
NCT01116882_inc_T69
Negation
not
NCT01116882_inc_T70
Qualifier
non-infarct-related artery
NCT01116882_inc_T71
Value
70% or greater
NCT01116882_inc_T72
Measurement
stenosis
NCT01116882_inc_T73
Condition
stenosis
NCT01116882_inc_T74
Scope
in an infarct (if not treated with primary PCI) or non-infarct-related artery
NCT01116882_inc_T75
Temporal
more than 72 hours following the ST segment elevation myocardial infarction (STEMI)
NCT01116882_inc_T76
Reference_point
the ST segment elevation myocardial infarction (STEMI)
NCT01116882_inc_T77
Condition
ST segment elevation myocardial infarction (STEMI)